These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1344593)
1. Metabolic changes in various types of recurrent urolithiasis. Hrebícek J Acta Univ Palacki Olomuc Fac Med; 1992; 133():25-30. PubMed ID: 1344593 [No Abstract] [Full Text] [Related]
2. [Magnesium excretion in recurrent calcium urolithiasis]. Pfab R; Hegemann M; Schütz W; Böttger I Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380 [TBL] [Abstract][Full Text] [Related]
3. [The value attached to clinical laboratory findings in urolithiasis (author's transl)]. Zechner O; Höltl G; Zekoff K; Zekert F Wien Klin Wochenschr; 1974 Nov; 86(21):654-7. PubMed ID: 4428778 [No Abstract] [Full Text] [Related]
4. A biochemical basis for grouping of patients with urolithiasis. Tiselius HG; Almgård LE; Larsson L; Sörbo B Eur Urol; 1978; 4(4):241-9. PubMed ID: 668734 [TBL] [Abstract][Full Text] [Related]
5. Excretion of urinary phosphate and magnesium on three diets in patients with urolithiasis. Juuti M; Alhava EM; Lammi S Ann Clin Res; 1981 Feb; 13(1):1-5. PubMed ID: 7247320 [TBL] [Abstract][Full Text] [Related]
6. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents]. Murayama T; Taguchi H Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487 [TBL] [Abstract][Full Text] [Related]
7. Uricemia and urolithiasis. Smith MJ; Hunt LD; King JS; Boyce WH J Urol; 1969 May; 101(5):637-42. PubMed ID: 5780596 [No Abstract] [Full Text] [Related]
8. [Renal electrolyte excretion in urolithiasis patients with special reference to primary hyperparathyroidism]. Horn HD Urologe; 1966 Sep; 5(5):258-63. PubMed ID: 5993169 [No Abstract] [Full Text] [Related]
9. Screening for biochemical abnormalities in urolithiasis patients. Orakzai N; Hanbury DC; Farrington K J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621 [TBL] [Abstract][Full Text] [Related]
10. [Prevention of recurrence in urolithiasis]. Terhorst B; Melchior H Z Urol Nephrol; 1969; 62(10):761-73. PubMed ID: 4326184 [No Abstract] [Full Text] [Related]
11. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium]. Murayama T; Taguchi H Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789 [TBL] [Abstract][Full Text] [Related]
12. Effect of urinary intestinal diversion on urinary risk factors for urolithiasis. Terai A; Arai Y; Kawakita M; Okada Y; Yoshida O J Urol; 1995 Jan; 153(1):37-41. PubMed ID: 7966785 [TBL] [Abstract][Full Text] [Related]
13. [Urinary magnesium and its relationship to calcium in recurrent stone-formers and controls (author's transl)]. Leskovar P; Hartung R; Siebert A; Wellnhofer E Urologe A; 1980 Jul; 19(4):214-9. PubMed ID: 7414766 [TBL] [Abstract][Full Text] [Related]
14. [Recurrent urolithiasis--analysis of its etiology and treatment]. Murakami M; Yamaguchi K; Mori I; Naito H; Miyauchi T; Ito H; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1982 Nov; 73(11):1402-9. PubMed ID: 7154469 [No Abstract] [Full Text] [Related]
15. The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism. Jorgensen FS; Transbol I Acta Med Scand; 1973 Oct; 194(4):327-34. PubMed ID: 4749172 [No Abstract] [Full Text] [Related]
16. Metabolic and clinical disturbances in patients with calcium urolithiasis. Smith LH; Werness PG; Wilson DM Scand J Urol Nephrol Suppl; 1980; 53():213-20. PubMed ID: 6937998 [No Abstract] [Full Text] [Related]
17. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients. Murayama T; Sakai N; Yamada T; Takano T Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477 [TBL] [Abstract][Full Text] [Related]
18. [Urine saturation with calcium oxalate in urolithiasis]. Bogado CE; Zanchetta JR Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787 [No Abstract] [Full Text] [Related]
19. The bronchodilator activity of AY-22093, a prostanoic acid derivative. Beck CW; Mulvaney WP; Rhamy RK; Gibson RI J Urol; 1974 May; 111(5):673-5. PubMed ID: 4823976 [No Abstract] [Full Text] [Related]
20. Magnesium excretion in patients with urinary lithiasis. Scott R; Sinclair J; Fell GS; Wilson R J R Coll Surg Edinb; 1974 Jul; 19(4):244-6. PubMed ID: 4841754 [No Abstract] [Full Text] [Related] [Next] [New Search]